London health tech startup that's looking to "solve obesity" raises $10m
Health tech startup OurPath has rebranded as Second Nature and raised $10million in a funding round led by Beringea.
The company is the first “lifestyle change programme” to be commissioned by the NHS for diabetes management.
It says it creates habit change through a more intensive and personalised approach - combining advice from health experts with tracking technology on an app - and claims that 10,000 of its participants revealed an average weight loss of 5.9kg after 12 weeks.
The new round includes investments from Uniqa Ventures, Connect, Speedinvest, Bethnal Green Ventures and the founders of mySugr, the digital diabetes management platform which was acquired by Roche.
Philip Edmondson-Jones, investment manager at Beringea who led the investment and joins the board of directors of Second Nature, said: “Healthcare systems are struggling to cope with spiralling rates of obesity and associated illnesses, which are projected to cost the global economy $1.2 trillion annually by 2025.
"Second Nature’s pioneering approach to lifestyle change empowers people to address these conditions.”
Founded in 2015 by two former NHS advisors, Chris Edson and Mike Gibbs, the company now employs 80 people.
Gibbs said: “Our goal as Second Nature is to solve obesity. We need to rise above the confusing health misinformation to provide clarity about what’s really important: changing habits. Our new brand and investment will help us realise that."